Ibm Retirement Fund Neurocrine Biosciences Inc Transaction History

Ibm Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$79.65 - $106.22 $209,399 - $279,252	-2,629 Closed	0 $0
Q2 2021 Jul 12, 2021	SELL	$89.43 - $102.27 $43,999 - $50,316	-492 Reduced 15.76%	2,629 $256,000
Q1 2021 Apr 22, 2021	SELL	$87.57 - $119.4 $23,118 - $31,521	-264 Reduced 7.8%	3,121 $304,000
Q4 2020 Jan 25, 2021	BUY	$86.91 - $108.33 $34,416 - $42,898	396 Added 13.25%	3,385 $324,000
Q3 2020 Oct 16, 2020	BUY	$96.16 - $135.15 $80,774 - $113,526	840 Added 39.09%	2,989 $287,000
Q2 2020 Jul 08, 2020	BUY	$85.09 - $130.36 $182,858 - $280,143	2,149 New	2,149 $262,000

627

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.3B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.